Abiopharma

🔍 Anhalt Rona (Executive)

Company: Certara, Inc. (CERT)

Report Date: 2026-04-01

Detailed Transactions and Holdings:

• Acquired 9,764 shares of Common Stock (Direct)
  Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 14,945.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 3,062 shares of Common Stock at $5.7 per share (Direct)
  Date: 2026-04-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 11,883.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 9,764 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-01 | Code: M | Expires: 2028-04-01 | equity_swap_involved: 0 | shares_owned_after: 19,528.00 | transaction_form_type: 4 | Footnotes: F1, F1

Footnotes:

• F1: Each restricted stock unit ("RSU") was granted on May 20, 2025, under the Certara, Inc. ("Certara") 2020 Incentive Plan and represents a right to receive one share of common stock or the cash equivalent. One-third of the RSUs vested and were settled on April 1, 2026. The remaining two-thirds of the RSUs will vest and settle in equal parts on April 1, 2027 and April 1, 2028.
• F2: Represents shares of Certara withheld to satisfy tax withholding obligations in connection with the vesting of RSUs exempt, under Rule 16b-3.